4.5 Article

Industry Payments to Practicing US Rheumatologists, 2014-2019

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Aneuromuscular-basedanalysis of the open payments program

Yohei Harada et al.

Summary: Based on data from the CMS OPP database, payments to neuromuscular neurologists in the US increased more than 6-fold from 2014 to 2018. The top 10% of physician-beneficiaries collected the vast majority of total industry payments. In 2018, the most common drugs associated with payments to neuromuscular neurologists included nusinersen and vortioxetine.

MUSCLE & NERVE (2021)

Review Medicine, General & Internal

Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review

Aaron P. Mitchell et al.

Summary: The study found that financial payments from the drug industry to U.S. physicians are associated with physician prescribing practices, including increased prescribing of the paying company's drug, increased prescribing costs, and increased prescribing of branded drugs.

ANNALS OF INTERNAL MEDICINE (2021)

Article Rheumatology

Key opinion leaders - a critical perspective

Jose U. Scher et al.

Summary: The authors critically evaluate the current opinion-based academia-industry interactions, advocating for partnerships that foster innovation and knowledge. Progress in rheumatology has historically been led by academic innovators, but with increased pharmaceutical industry involvement, funds are now mostly directed towards influencing prescription behavior rather than innovation. Rebalancing academia-industry partnerships towards academic research and innovation leaders is crucial for sustainable long-term critical research and maximizing returns on investment.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Oncology

Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019

Elizabeth S. Tarras et al.

Summary: From 2014 to 2019, a cohort of 15,585 US medical oncologists became less likely to receive industry payments, but the overall value of the payments increased. Over time, medical oncologists receiving lower-value payments (<$10,000) accepted smaller amounts and those receiving higher-value payments (>$10,000) accepted larger amounts. The trend in industry payments to medical oncologists since the inception of the Open Payments program highlights the limitations of transparency without accountability in policy making.

JAMA ONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Gender differences in industry payments among cardiologists

Inbar Raber et al.

AMERICAN HEART JOURNAL (2020)

Article Rheumatology

The Quality of Randomized Controlled Trials in High-impact Rheumatology Journals, 1998-2018

Michael S. Putman et al.

JOURNAL OF RHEUMATOLOGY (2020)

Editorial Material Rheumatology

The Never-Ending Conflict (of Interest)

Rouhin Sen et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Trends in reported industry payments to physicians practicing cardiac electrophysiology from 2013 to 2018 in the United States

Andrew S. Tseng et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2020)

Article Medicine, General & Internal

Association Between Industry Payments to Physicians and Device Selection in ICD Implantation

Amarnath R. Annapureddy et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, General & Internal

Trends in Industry Payments to Physicians in the United States From 2014 to 2018

Deborah C. Marshall et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Medicine, General & Internal

Older Drugs With Limited Trial Evidence: Are They Worth the Expense? The Case of Repository Corticotropin Marketed as HP Acthar Gel

Ali Duarte-Garcia et al.

ANNALS OF INTERNAL MEDICINE (2019)

Letter Health Care Sciences & Services

Association of Pharmaceutical Manufacturer Payments to Physicians and Prescribing Dosage of Opioids

William Fleischman et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2019)

Letter Health Care Sciences & Services

Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries

Partik Singh et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2019)

Article Medicine, General & Internal

Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin

Daniel M. Hartung et al.

JAMA NETWORK OPEN (2018)

Article Medicine, General & Internal

Types and Distribution of Payments From Industry to Physicians in 2015

Kathryn R. Tringale et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries

Colette DeJong et al.

JAMA INTERNAL MEDICINE (2016)

Article Medicine, General & Internal

Spending Patterns in Region of Residency Training and Subsequent Expenditures for Care Provided by Practicing Physicians for Medicare Beneficiaries

Candice Chen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Rheumatology

Ethical Challenges in Rheumatology A Survey of the American College of Rheumatology Membership

C. Ronald MacKenzie et al.

ARTHRITIS AND RHEUMATISM (2013)